Healthcare Brew

Healthcare Brew

A newsletter designed to help you understand the healthcare sector. Receive the most recent news and valuable insights about the intricate healthcare landscape directly in your inbox, twice a week.

National
English
Newsletter (Digital)

Outlet metrics

Domain Authority
40
Ranking

Global

#386172

United States

#95575

Health/Medicine

#839

Traffic sources
Monthly visitors

Articles

  • 1 week ago | healthcare-brew.com | Caroline Catherman

    Are you curious about all the ways that multimillion-dollar medtech can go wrong? If so, you’re in the right place!Welcome to Recall Roundup, a noncomprehensive roundup of recent FDA Class I recalls—the most severe and potentially life-threatening kind. Recalls range from correcting an issue to removing a device from the market altogether. With that, let’s get into it!Blood products administration set recall.

  • 1 week ago | healthcare-brew.com | Caroline Catherman

    Welcome to June’s On Rotation!Each month, we highlight some of the major job changes in the healthcare sector, from small startups bringing in new leadership to big orgs trading seasoned execs. Here’s a noncomprehensive roundup of the past month’s career shifts. Have a job announcement to share? Drop Caroline an email at .

  • 1 week ago | healthcare-brew.com | Caroline Catherman

    This year has been a rollercoaster for the pharmaceutical industry, and at this point, it’s unclear whether the ride is about to stop or if we’re at the top of another drop. The industry overall has posted mixed earnings so far, with companies performing better than expected in some categories but falling short in others, Healthcare Brew previously reported.

  • 1 week ago | healthcare-brew.com | Caroline Catherman

    Hospitals and third-party companies have long been cleaning, retesting, and reusing medical devices, including those labeled as single-use, an approach known as “reprocessing.”Often, this can help cut down medical waste and save money, and it doesn’t appear to compromise safety: As of 2000, the FDA requires reprocessed devices to meet the same formal regulatory standards of the original products, including premarket testing.

  • 2 weeks ago | healthcare-brew.com | Caroline Catherman

    With tariffs on the way “very shortly” for imported drugs, pharma giants like and Johnson & Johnson are investing billions into expanding US manufacturing. On the surface, it seems like tariffs are accomplishing the promised goal of bringing manufacturing back to the US.

Healthcare Brew journalists